TcLand Expression-Product Pipeline Analysis, 2017 Update
- GDME131127PD
- Pages: 22
- July 2017
- Total Views:1200
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
TcLand Expression (TcLand) is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, IMD Dx2, IMD Dx3 and L-TolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company TcLand Expression
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TcLand Expression Company Overview 4
TcLand Expression Company Snapshot 4
TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4
TcLand Expression-Pipeline Analysis Overview 7
TcLand Expression-Key Facts 7
TcLand Expression-Major Products and Services 8
TcLand Expression Pipeline Products by Development Stage 9
TcLand Expression Pipeline Products Overview 11
IMD Dx2 11
IMD Dx2 Product Overview 11
IMD Dx3 12
IMD Dx3 Product Overview 12
L-TolX 13
L-TolX Product Overview 13
RA-INF-Dx 14
RA-INF-Dx Product Overview 14
TcLand Expression-Key Competitors 15
TcLand Expression-Key Employees 16
TcLand Expression-Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
TcLand Expression, Recent Developments 18
Jun 17, 2011: TcLand Expression Receives EUR1.2m From Oseo And ERDF To Support Project In Personalized Medicine 18
Appendix 19
Methodology 19
About GlobalData 21
Contact Us 21
Disclaimer 21
List Of Figure
List of Figures
TcLand Expression Pipeline Products by Equipment Type 5
TcLand Expression Pipeline Products by Development Stage 9
List Of Table
List of Tables
TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4
TcLand Expression Pipeline Products by Equipment Type 5
TcLand Expression Pipeline Products by Indication 6
TcLand Expression, Key Facts 7
TcLand Expression, Major Products and Services 8
TcLand Expression Number of Pipeline Products by Development Stage 9
TcLand Expression Pipeline Products Summary by Development Stage 10
IMD Dx2-Product Status 11
IMD Dx2-Product Description 11
IMD Dx3-Product Status 12
IMD Dx3-Product Description 12
L-TolX-Product Status 13
L-TolX-Product Description 13
RA-INF-Dx-Product Status 14
RA-INF-Dx-Product Description 14
TcLand Expression, Key Employees 16
Glossary 20
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
TcLand Expression, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Company Profile
Company Profile Title
Summary
TcLand Expression (TcLand) is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, IMD Dx2, IMD Dx3 and L-TolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company TcLand Expression
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TcLand Expression Company Overview 4
TcLand Expression Company Snapshot 4
TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4
TcLand Expression-Pipeline Analysis Overview 7
TcLand Expression-Key Facts 7
TcLand Expression-Major Products and Services 8
TcLand Expression Pipeline Products by Development Stage 9
TcLand Expression Pipeline Products Overview 11
IMD Dx2 11
IMD Dx2 Product Overview 11
IMD Dx3 12
IMD Dx3 Product Overview 12
L-TolX 13
L-TolX Product Overview 13
RA-INF-Dx 14
RA-INF-Dx Product Overview 14
TcLand Expression-Key Competitors 15
TcLand Expression-Key Employees 16
TcLand Expression-Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
TcLand Expression, Recent Developments 18
Jun 17, 2011: TcLand Expression Receives EUR1.2m From Oseo And ERDF To Support Project In Personalized Medicine 18
Appendix 19
Methodology 19
About GlobalData 21
Contact Us 21
Disclaimer 21
List Of Figure
List of Figures
TcLand Expression Pipeline Products by Equipment Type 5
TcLand Expression Pipeline Products by Development Stage 9
List Of Table
List of Tables
TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4
TcLand Expression Pipeline Products by Equipment Type 5
TcLand Expression Pipeline Products by Indication 6
TcLand Expression, Key Facts 7
TcLand Expression, Major Products and Services 8
TcLand Expression Number of Pipeline Products by Development Stage 9
TcLand Expression Pipeline Products Summary by Development Stage 10
IMD Dx2-Product Status 11
IMD Dx2-Product Description 11
IMD Dx3-Product Status 12
IMD Dx3-Product Description 12
L-TolX-Product Status 13
L-TolX-Product Description 13
RA-INF-Dx-Product Status 14
RA-INF-Dx-Product Description 14
TcLand Expression, Key Employees 16
Glossary 20
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
TcLand Expression, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies